The first human received an implant from Neuralink yesterday and is recovering well," Musk announced on Twitter late Monday. "Initial results show promising neuron spike detection."
The California-based company, founded in 2016, got the green light from federal regulators at the Food and Drug Administration in September to begin human trials, an Neuralink put out an open call for volunteers for its PRIME study, the mixed acronym standing for "Precise Robotically Implanted Brain-Computer Interface."
Buzz about the company's progress was tempered somewhat in November, however, when a Reuters report detailed the painful and sometimes grotesque outcomes of its testing on animals.
No futher details on the Sunday procedure or its subject was made available, the Neuralink company blog last updated nearly five months ago.
This is a developing story and will be updated as information becomes available.